Scarica l'app Stockscreener
18.45
1.60%
0.29
Precedente Chiudi:
$18.16
Aprire:
$18.35
Volume 24 ore:
270.91K
Relative Volume:
0.85
Capitalizzazione di mercato:
$748.50M
Reddito:
-
Utile/perdita netta:
$-136.98M
Rapporto P/E:
-4.5896
EPS:
-4.02
Flusso di cassa netto:
$-126.63M
1 W Prestazione:
+0.99%
1M Prestazione:
-3.50%
6M Prestazione:
-0.22%
1 anno Prestazione:
-21.49%
Intervallo 1D:
$18.10
$18.69
Intervallo di 1 settimana:
$17.04
$18.79
Portata 52W:
$15.47
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
Nome
Arrivent Biopharma Inc
Settore
Industria
Telefono
240-780-6356
Indirizzo
18 CAMPUS BLVD., NEWTOWN SQUARE
Confronta AVBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
18.45 | 736.73M | 0 | -136.98M | -126.63M | -4.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2025-03-20 | Iniziato | B. Riley Securities | Buy |
| 2025-03-10 | Iniziato | Guggenheim | Buy |
| 2024-07-22 | Iniziato | Oppenheimer | Outperform |
| 2024-04-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-02-20 | Iniziato | Citigroup | Buy |
| 2024-02-20 | Iniziato | Goldman | Buy |
| 2024-02-20 | Iniziato | Jefferies | Buy |
Mostra tutto
Arrivent Biopharma Inc Borsa (AVBP) Ultime notizie
Certain Options of ArriVent BioPharma, Inc. are subject to a Lock-Up Agreement Ending on 1-OCT-2025. - MarketScreener
Certain Common Stock of ArriVent BioPharma, Inc. are subject to a Lock-Up Agreement Ending on 1-OCT-2025. - MarketScreener
Is it too late to sell ArriVent BioPharma Inc.Risk Management & Low Risk High Win Rate Picks - newser.com
Will ArriVent BioPharma Inc. stock see PE expansion2025 Market Outlook & Weekly High Momentum Picks - newser.com
Is ArriVent BioPharma Inc. stock attractive after correctionJuly 2025 PostEarnings & Free Real-Time Volume Trigger Notifications - newser.com
Analyzing drawdowns of ArriVent BioPharma Inc. with statistical toolsWeekly Market Summary & Stock Market Timing Techniques - newser.com
How moving averages guide ArriVent BioPharma Inc. tradingTrade Analysis Summary & AI Optimized Trade Strategies - newser.com
ArriVent BioPharma Taps Brent S. Rice as Chief Commercial Officer - MyChesCo
ArriVent BioPharma Reports Q1 2025 Financial Results and Highlights Key Achievements - MSN
ArriVent Reports Promising Results for Firmonertinib in Lung Cancer Patients With Rare EGFR Mutations - MSN
Can S.P.E.E.H. Hidroelectrica S.A. (E28) stock hold up in economic slowdownJuly 2025 Patterns & AI Powered Market Entry Strategies - newser.com
Is it time to cut losses on ArriVent BioPharma Inc.2025 Institutional Moves & Fast Moving Market Watchlists - newser.com
Custom watchlist performance reports with ArriVent BioPharma Inc. - newser.com
Goldman Sachs Group Inc. Reduces Holdings in ArriVent BioPharma, Inc. $AVBP - MarketBeat
ArriVent BioPharma appoints Brent Rice as chief commercial officer - Investing.com
ArriVent BioPharma appoints Brent Rice as chief commercial officer By Investing.com - Investing.com Nigeria
ArriVent Appoints Brent Rice as Chief Commercial Officer - citybiz
ArriVent Biopharma appoints Brent Rice as chief commercial officer - TipRanks
Arrivent appoints Brent S. Rice as Chief Commercial Officer - MarketScreener
ArriVent BioPharma Names Brent S. Rice as CCO - MarketScreener
ArriVent BioPharma Announces Appointment of Brent S. Rice as Chief Commercial Officer - Quiver Quantitative
ArriVent Appoints Brent S. Rice as Chief Commercial Officer - The Manila Times
Oncology Biotech ArriVent BioPharma Taps 25-Year Industry Veteran to Lead Lung Cancer Drug Launch - Stock Titan
Will earnings trigger a reversal in ArriVent BioPharma Inc.Quarterly Earnings Report & Consistent Profit Trading Strategies - newser.com
Institutional scanner results for Baker Hughes CompanyTrade Signal Summary & Daily Technical Forecast Reports - newser.com
Is ArriVent BioPharma Inc. forming a bottoming baseWeekly Trend Report & Consistent Income Trade Ideas - newser.com
Is ArriVent BioPharma Inc. stock ready for a breakoutPortfolio Profit Report & Free Community Consensus Stock Picks - newser.com
How to track smart money flows in ArriVent BioPharma Inc.Weekly Stock Summary & High Conviction Buy Zone Picks - newser.com
Resistance Check: What is the long term forecast for HP Inc stockJuly 2025 Rallies & Entry Point Strategy Guides - خودرو بانک
Quarterly Earnings: What is the cash position of ArriVent BioPharma IncJuly 2025 PostEarnings & Free Fast Gain Swing Trade Alerts - خودرو بانک
Chart based exit strategy for ArriVent BioPharma Inc.Trade Analysis Summary & Short-Term High Return Strategies - newser.com
Aug Swings: How do insiders feel about ArriVent BioPharma Inc2025 Biggest Moves & AI Forecast Swing Trade Picks - خودرو بانک
Aug Retail: Can Aris Mining Corporation be the next market leaderPortfolio Performance Summary & Real-Time Stock Price Movement Reports - khodrobank.com
Aug Setups: Will Outdoor Holding Company stock recover after earnings2025 Analyst Calls & Community Consensus Trade Alerts - khodrobank.com
NiKang Therapeutics Advances First-in-Class CDK2/4 Dual Degrader in Phase 1 Study - MyChesCo
Has ArriVent BioPharma Inc. found a price floorJuly 2025 Update & Accurate Technical Buy Alerts - newser.com
Breakout Watch: Is China Automotive Systems Inc stock heavily shorted2025 Performance Recap & Breakout Confirmation Trade Signals - خودرو بانک
Is ArriVent BioPharma Inc. building a consolidation baseEarnings Beat & Stepwise Trade Signal Implementation - newser.com
Update Report: Will ArriVent BioPharma Inc. benefit from AI trends2025 Key Highlights & Verified Swing Trading Watchlist - khodrobank.com
Breakout Watch: Does ArriVent BioPharma Inc stock have upside surprise potentialWeekly Volume Report & Precise Swing Trade Entry Alerts - khodrobank.com
Day Trade: Is ArriVent BioPharma Inc showing insider buyingJuly 2025 Rallies & Free Real-Time Volume Trigger Notifications - خودرو بانک
Wall Street Recap: Whats the profit margin of ArriVent BioPharma IncWeekly Trading Summary & Stepwise Entry and Exit Trade Signals - خودرو بانک
Arrivent Biopharma Inc Azioni (AVBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):